Startups
Nanoligent

Research and development of innovative cancer treatments using protein nanoparticles for clinical phases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 63

Locations

Last Stage Round

Industry

Total Funding
$1.1M
Investors
Full Company Profile